immunology antigen ag molecule moiety foreign particulate matter allergen pollen bind specific antibody tcell presence antigens body may trigger immune antigens proteins peptides amino acid chains polysaccharides chains simple sugars lipids nucleic antigens exist normal cells cancer cells parasites viruses fungi antigens recognized antigen receptors including antibodies tcell diverse antigen receptors made cells immune system cell specificity single upon exposure antigen lymphocytes recognize antigen activated expanded process known clonal cases antibodies antigenspecific meaning antibody react bind one specific antigen instances however antibodies may crossreact bind one antigen reaction antigen antibody called antigenantibody reaction antigen originate either within body selfprotein self antigens external environment immune system identifies attacks nonself external antigens antibodies usually react selfantigens due negative selection cells thymus b cells bone diseases antibodies react self antigens damage bodys cells called autoimmune vaccines examples antigens immunogenic form intentionally administered recipient induce memory function adaptive immune system towards antigens pathogen invading recipient vaccine seasonal influenza common paul ehrlich coined term antibody german antikörper sidechain theory end ladislas deutsch lászló detre named hypothetical substances halfway bacterial constituents antibodies antigenic immunogenic substances french substances immunogènes ou antigènes originally believed substances precursors antibodies zymogen precursor enzyme understood antigen induces production immune bodies antibodies wrote word antigen contraction antisomatogen immunkörperbildner oxford english dictionary indicates logical construction term originally referred substance acts antibody antigenpresenting cells present antigens form peptides histocompatibility molecules cells selectively recognize antigens depending antigen type histocompatibility molecule different types cells activated tcell receptor tcr recognition peptide must processed small fragments inside cell presented major histocompatibility complex antigen elicit immune response without help immunologic similarly adjuvant component vaccines plays essential role activation innate immune immunogen antigen substance adduct able trigger humoral innate cellmediated immune first initiates innate immune response causes activation adaptive immune response antigen binds highly variable immunoreceptor products bcell receptor tcell receptor generated immunogens antigens termed immunogenic capable inducing immune molecular level antigen characterized ability bind antibodys paratopes different antibodies potential discriminate among specific epitopes present antigen surface hapten small molecule induce immune response attached larger carrier molecule protein antigens proteins polysaccharides lipids nucleic acids includes parts coats capsules cell walls flagella fimbriae toxins bacteria viruses microorganisms nonmicrobial nonself antigens include pollen egg white proteins transplanted tissues organs surface transfused blood cells antigens classified according source exogenous antigens antigens entered body outside example inhalation ingestion injection immune systems response exogenous antigens often subclinical endocytosis phagocytosis exogenous antigens taken antigenpresenting cells apcs processed fragments apcs present fragments helper cells use class ii histocompatibility molecules surface cells specific peptidemhc complex become activated start secrete cytokines substances activate cytotoxic lymphocytes ctl antibodysecreting b cells macrophages particles antigens start exogenous later become endogenous example intracellular viruses intracellular antigens returned circulation upon destruction infected cell endogenous antigens generated within normal cells result normal cell metabolism viral intracellular bacterial infection fragments presented cell surface complex mhc class molecules activated cytotoxic cells recognize cells secrete various toxins cause lysis apoptosis infected cell order keep cytotoxic cells killing cells presenting selfproteins cytotoxic cells selfreactive cells deleted result tolerance negative selection endogenous antigens include xenogenic heterologous autologous idiotypic allogenic homologous antigens sometimes antigens part host autoimmune autoantigen usually selfprotein protein complex sometimes dna rna recognized immune system patients specific autoimmune disease normal conditions selfproteins target immune system autoimmune diseases associated cells deleted instead attack neoantigens entirely absent normal human genome compared nonmutated selfproteins neoantigens relevance tumor control quality cell pool available antigens affected central cell tolerance technology systematically analyze cell reactivity neoantigens became available neoantigens directly detected virusassociated tumors cervical cancer subset head neck cancers epitopes derived viral open reading frames contribute pool tumor antigens antigens presented mhc class mhc class ii molecules surface tumor cells antigens found cells called tumorspecific antigens tsas generally result tumorspecific mutation common antigens presented tumor cells normal cells called tumorassociated antigens taas cytotoxic lymphocytes recognize antigens may able destroy tumor tumor antigens appear surface tumor form example mutated receptor case recognized b human tumors without viral etiology novel peptides neoepitopes created tumorspecific dna large fraction human tumor mutations effectively patientspecific therefore neoantigens may also based individual tumor genomes deepsequencing technologies identify mutations within proteincoding part genome exome predict potential neoantigens mice models novel protein sequences potential mhcbinding peptides predicted resulting set potential neoantigens used assess cell reactivity analyses exploited clinical setting assess reactivity patients treated either tumorinfiltrating lymphocyte til cell therapy checkpoint blockade neoantigen identification successful multiple experimental model systems human falsenegative rate cancer exome sequencing majority neoantigens occur within exonic sequence sufficient coverage however vast majority mutations within expressed genes produce neoantigens recognized autologous mass spectrometry resolution insufficient exclude many false positives pool peptides may presented mhc molecules instead algorithms used identify likely candidates algorithms consider factors likelihood proteasomal processing transport endoplasmic reticulum affinity relevant mhc class alleles gene expression protein translation majority human neoantigens identified unbiased screens display high predicted mhc binding affinity minor histocompatibility antigens conceptually similar antigen class also correctly identified mhc binding algorithms another potential filter examines whether mutation expected improve mhc binding nature central tcrexposed residues mhcbound peptides associated peptide native antigen antigen yet processed apc smaller parts cells bind native antigens require processed apcs whereas b cells activated native ones antigenic specificity ability host cells recognize antigen specifically unique molecular entity distinguish another exquisite precision antigen specificity due primarily sidechain conformations antigen measurable need linear ratelimited step cells b cells cellular components adaptive httpsenwikipediaorgwikiantigen